Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
new steady state | stable repeating exposure after a regimen or clearance change | Review the interval since dose reduction before assuming a new steady state. | Plan | Drug levels - verification and documentation |
Bayesian estimation | model-based estimate combining prior information and patient data | The consult used Bayesian estimation and listed the samples entered. | Plan | Drug levels - verification and documentation |
model fit | agreement between a model and measured observations | Review the model fit against the timed concentrations. | Plan | Drug levels - verification and documentation |
extrapolation | estimation beyond the directly observed sampling time | Label the estimated peak as an extrapolation. | Plan | Drug levels - verification and documentation |
back-extrapolated peak | peak estimated retrospectively from a later concentration and a model | Record the back-extrapolated peak separately from the measured sample. | Plan | Drug levels - verification and documentation |
predicted trough | estimated concentration at the end of a future or modeled interval | Distinguish the predicted trough from the actual predose measurement. | Plan | Drug levels - verification and documentation |
assay confirmation | additional laboratory verification of the measured result | Contact the laboratory to request assay confirmation of the unexpected value. | Plan | Drug levels - verification and documentation |
independent specimen | new sample collected independently of the prior sample | Document the site and timing of the independent specimen. | Plan | Drug levels - verification and documentation |
critical notification | communication required by the laboratory's critical-result policy | Document the time, recipient and readback of the critical notification. | Plan | Drug levels - verification and documentation |
laboratory comment | interpretive or technical annotation accompanying a result | Include the laboratory comment about possible interference. | Plan | Drug levels - verification and documentation |
unchanged regimen | dose and schedule remained the same over the stated interval | Confirm an unchanged regimen and review missed doses before classifying steady state. | Plan | Drug levels - verification and documentation |
dose-to-draw interval | time between administration and collection | Calculate the dose-to-draw interval from the actual timestamps. | Plan | Drug levels - verification and documentation |
infusion-to-draw interval | elapsed time from infusion completion to collection | Verify the infusion-to-draw interval from the pump record. | Plan | Drug levels - verification and documentation |
comparison target | specific benchmark used to judge a concentration | Match the comparison target to the indication and specimen type. | Plan | Drug levels - verification and documentation |
paired sampling | two protocol-timed specimens considered together | Coordinate paired sampling and document both collection times. | Plan | Drug levels - verification and documentation |
laboratory consultation | discussion with the laboratory about a result or assay | Request laboratory consultation about the discrepancy between assay methods. | Plan | Drug levels - verification and documentation |
| units attached to the measured laboratory value | Verify the assay units before comparing the outside result. | Plan | Drug levels - verification and documentation | |
target attainment | achievement of the defined treatment exposure goal | Evaluate target attainment only after checking the metric, timing and comparator. | Plan | Drug levels - verification and documentation |
vancomycin | glycopeptide antibiotic measured for exposure monitoring in selected settings | The vancomycin report lists a measured concentration and a separate estimated AUC24. | Objective | Drug levels - named analytes and exposure reports |
gentamicin | aminoglycoside monitored using regimen-specific sampling | The gentamicin result is paired with the infusion end time and draw time. | Objective | Drug levels - named analytes and exposure reports |
tobramycin | aminoglycoside with regimen-dependent sampling and interpretation | The tobramycin sample is labeled as a timed level on the extended-interval regimen. | Objective | Drug levels - named analytes and exposure reports |
amikacin | aminoglycoside with drug- and regimen-specific concentration targets | The amikacin concentration is documented with the dialysis session time. | Objective | Drug levels - named analytes and exposure reports |
digoxin | cardiac glycoside for which dose-to-draw time affects concentration interpretation | The digoxin result was collected two hours after the reported dose. | Objective | Drug levels - named analytes and exposure reports |
lithium | mood stabilizer measured with a timed blood concentration | The lithium level is documented with the evening dose and morning draw times. | Objective | Drug levels - named analytes and exposure reports |
phenytoin | antiseizure medicine measured as free or total drug | The phenytoin result on the original report is explicitly labeled total. | Objective | Drug levels - named analytes and exposure reports |